Bio-Techne TECH Deferred Revenue
Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's deferred revenue?
- Bio-Techne (TECH) reported deferred revenue of $38.43M in Q1 2026.
- How has Bio-Techne's deferred revenue changed year-over-year?
- Bio-Techne's deferred revenue increased by 19.1% year-over-year, from $32.27M to $38.43M.
- What is the long-term trend for Bio-Techne's deferred revenue?
- Over 4 years (2021 to 2025), Bio-Techne's deferred revenue has grown at a 14.4% compound annual growth rate (CAGR), from $19M to $32.57M.
- What does deferred revenue mean?
- Money collected from customers for work or products that have not been delivered yet.
- How do you interpret deferred revenue?
- An increase is a positive leading indicator of future revenue recognition and strong customer demand.
- How does deferred revenue compare across companies?
- Higher balances are common in companies with subscription or long-term service models.